KIMBERLY SIMON: Open Payments
NPI 1053553974 · FLEMING ISLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,745 in 126 payments from 23 companies in 2025. Trend: 2023 $1,308 · 2024 $1,850 · 2025 $2,745
Food & beverage: $2,745
| Company | Payments | Amount |
|---|---|---|
| MicroTransponder, Inc. | 1 | $265 |
| ABBVIE INC. | 19 | $255 |
| Novartis Pharmaceuticals Corporation | 11 | $251 |
| Lilly USA, LLC | 11 | $249 |
| Teva Pharmaceuticals USA, Inc. | 18 | $231 |
| Lundbeck LLC | 11 | $223 |
| Axsome Therapeutics, Inc. | 7 | $179 |
| UCB, Inc. | 7 | $173 |
| PFIZER INC. | 9 | $150 |
| Medtronic, Inc. | 2 | $137 |
Products named: KESIMPTA, AUSTEDO XR, REXULTI, Symbravo, AMYVID, Nayzilam, NURTEC ODT, UBRELVY.
Industry payments across FL — which companies pay providers there.
